Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pagina 1 a partire dal 33 risultati
Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A ]pyridine
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to novel crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-a ]pyridine to pharmaceutical compositions containing such crystal forms and to methods of treatment.
Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to novel cycloalkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases,
Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
Solo gli utenti registrati possono tradurre articoli
Entra registrati
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No. 60/407,489, filed on Aug. 30, 2002.
The present invention relates to novel cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines, to intermediates for their preparation, to
Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to novel alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines, to intermediates and methods for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP
(Imidazolylmethyl)pyridine compounds as thromboxane synthetase inhibitors
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
This invention relates to pyridine derivatives and in particular to certain 2-(1-imidazolymethyl)pyridine derivatives substituted in the pyridine ring. Such compounds are able to selectively inhibit the action of the thromboxane synthetase enzyme without significantly
Pharmaceutically active disubstituted pyridine derivatives
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferative diseases, inflammatory and immunological
Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to novel triazolo-pyridines, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases, preferably p38 kinase. They are useful in the
Triazolo-pyridines anti-inflammatory compounds
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to novel triazolo-pyridines, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP kinases, preferably p38 kinase. They are useful in the
Pyridine derivatives
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to pyridine derivatives, to processes for their preparation and to pharmaceutical compositions containing them.
Up to now, of the compounds having a pyridine skeleton, it has been reported that 2-isopropyl-3-nicotinylindole(L-8027) possesses an inhibitory activity on
Pyridine derivatives
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to pyridine derivatives, to processes for their preparation and to pharmaceutical compositions containing them.
Up to now, of the compounds having a pyridine skeleton, it has been reported that 2-isopropyl-3-nicotinylindole(L-8027) possesses an inhibitory activity on
Triazolo-pyridines as anti-inflammatory compounds
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
The present invention relates to novel triazolo-pyridines, to methods of preparation, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the present invention are potent inhibitors of MAP
Pyridine alkyl benzoic and thenoic acid compounds and their pharmaceutical compositions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to pyridine derivatives, to processes for their preparation and to pharmaceutical compositions containing them.
Up to now, of the compounds having a pyridine skeleton, it has been reported that 2-isopropyl-3-nicotinylindole(L-8027) possesses an inhibitory activity on
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to certain imidazo[1,2-.alpha.]pyridine derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT.sub.2A serotonin receptor. Compounds of Formula (Ia) and pharmaceutical compositions thereof are
Imidazo[1,2-.alpha.]pyridine derivatives as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to certain imidazo[1,2-a]pyridine derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT.sub.2A serotonin receptor. Compounds of Formula (Ia) and pharmaceutical compositions thereof are directed
Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
This invention relates to compounds that inhibit the activity of protein kinases. Protein kinases are enzymes that catalyze the transfer of a phosphate group from ATP to an amino acid residue, such as tyrosine, serine, threonine, or histidine on a protein. Regulation of
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
